Who will regulate mHealth? Patient Engagement at Crossroads; New Alliance Takes On Interoperability
Chilmark Research
APRIL 3, 2013
Public vs. Private Oversight of Mobile Health. mHealth, known for rapid innovation and iteration, has a tendency to buck at the snail’s pace of FDA regulation. This could herald a new age of credibility for mHealth. Below are abstracts from this month’s update. John Moore III. The March Toward Better Patient Engagement.
Let's personalize your content